These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 8625943
1. Cell cycle traverse in AHH-1 tk +/- human lymphoblastoid cells exposed to the chromosomal mutagen, m-amsa. Morris SM, McGarrity LJ, Domon OE, Chen JJ, Casciano DA. Environ Mol Mutagen; 1996; 27(1):10-8. PubMed ID: 8625943 [Abstract] [Full Text] [Related]
2. Distinct patterns of cell cycle disturbance elicited by compounds interfering with DNA topoisomerase I and II activity. Poot M, Hiller KH, Heimpel S, Hoehn H. Exp Cell Res; 1995 May; 218(1):326-30. PubMed ID: 7537696 [Abstract] [Full Text] [Related]
3. Application of fluorescence in situ hybridisation to study the relationship between cytotoxicity, chromosome aberrations, and changes in chromosome number after treatment with the topoisomerase II inhibitor amsacrine. Ferguson LR, Whiteside G, Holdaway KM, Baguley BC. Environ Mol Mutagen; 1996 May; 27(4):255-62. PubMed ID: 8665870 [Abstract] [Full Text] [Related]
4. Effect of cell cycle on the regulation of the cell surface and secreted forms of type I and type II human tumor necrosis factor receptors. Pocsik E, Mihalik R, Penzes M, Loetscher H, Gallati H, Aggarwal BB. J Cell Biochem; 1995 Nov; 59(3):303-16. PubMed ID: 8567749 [Abstract] [Full Text] [Related]
5. Sequestration of mitotic (M-phase) chromosomes in autophagosomes: mitotic programmed cell death in human Chang liver cells induced by an OH* burst from vanadyl(4). Sit KH, Paramanantham R, Bay BH, Chan HL, Wong KP, Thong P, Watt F. Anat Rec; 1996 May; 245(1):1-8. PubMed ID: 8731032 [Abstract] [Full Text] [Related]
6. Embryotoxicity of the intercalating agents m-AMSA and o-AMSA and the epipodophyllotoxin VP-16 in postimplantation rat embryos in vitro. Mirkes PE, Zwelling LA. Teratology; 1990 Jun; 41(6):679-88. PubMed ID: 2162085 [Abstract] [Full Text] [Related]
7. Involvement of cell cycle control in bleomycin-induced mutagen sensitivity. Cloos J, Temmink O, Ceelen M, Snel MH, Leemans CR, Braakhuis BJ. Environ Mol Mutagen; 2002 Jun; 40(2):79-84. PubMed ID: 12203399 [Abstract] [Full Text] [Related]
9. Mechanism of resistance of noncycling mammalian cells to 4'-(9-acridinylamino)methanesulfon-m-anisidide: comparison of uptake, metabolism, and DNA breakage in log- and plateau-phase Chinese hamster fibroblast cell cultures. Robbie MA, Baguley BC, Denny WA, Gavin JB, Wilson WR. Cancer Res; 1988 Jan 15; 48(2):310-9. PubMed ID: 2825971 [Abstract] [Full Text] [Related]
12. Effect of cell proliferation and chromatin conformation on intercalator-induced, protein-associated DNA cleavage in human brain tumor cells and human fibroblasts. Zwelling LA, Estey E, Silberman L, Doyle S, Hittelman W. Cancer Res; 1987 Jan 01; 47(1):251-7. PubMed ID: 3024817 [Abstract] [Full Text] [Related]
13. [Effect of etoposide and amsacrine on mitotic progression of GM-130 and Hep-2 cell lines. The flow cytometry assay]. Shatrova AN, Aksenov ND, Poletaev AI, Zenin VV. Tsitologiia; 2003 Jan 01; 45(1):59-68. PubMed ID: 12683237 [Abstract] [Full Text] [Related]
14. Effect of curcumin on cell cycle progression and apoptosis in vascular smooth muscle cells. Chen HW, Huang HC. Br J Pharmacol; 1998 Jul 01; 124(6):1029-40. PubMed ID: 9720770 [Abstract] [Full Text] [Related]
16. Extracts from two marine sponges lower cyclin B1 levels, cause a G2/M cell cycle block and trigger apoptosis in SW-13 human adrenal carcinoma cells. Brown JW, Cappell S, Perez-Stable C, Fishman LM. Toxicon; 2004 Jun 01; 43(7):841-6. PubMed ID: 15284019 [Abstract] [Full Text] [Related]
17. The production of chromosomal alterations in human lymphocytes by drugs known to interfere with the activity of DNA topoisomerase II. I. m-AMSA. Andersson HC, Kihlman BA. Carcinogenesis; 1989 Jan 01; 10(1):123-30. PubMed ID: 2535969 [Abstract] [Full Text] [Related]
18. The cell cycle phases of DNA damage and repair initiated by topoisomerase II-targeting chemotherapeutic drugs. Potter AJ, Rabinovitch PS. Mutat Res; 2005 May 02; 572(1-2):27-44. PubMed ID: 15790488 [Abstract] [Full Text] [Related]